Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Meeting of CDFS's Department on Drugs
September 26, 2005
- NEW PRODUCTS
September 26, 2005
- JMA's Involvement in Recommendation of Reps. of Hosp. Org. Necessary: Korosho
September 26, 2005
- MARKET SURVEY
September 26, 2005
- REGULATORY NEWS IN BRIEF
September 26, 2005
- GENERICS NEWS IN BRIEF
September 26, 2005
- JPLA LECTURE
September 26, 2005
- Innovative Drugs Should Be Valued More Highly: Mr Otsuji
September 26, 2005
- Taisho Toyama Aims at \120 Mil. Sales per MR ASAP: Mr Uehara of Taisho
September 26, 2005
- Mr Fujii, New President of QTJ, Introduced by Dr Gillings
September 26, 2005
- Alfresa HD, Meisyo to Merge in April 2006
September 26, 2005
- BUSINESS NEWS IN BRIEF
September 26, 2005
- Greater Disclosure Raises Public's Confidence in Company: Dr Breier of Eli Lilly
September 26, 2005
- JPMA to Revise Guidance on Supply of Control Drugs
September 26, 2005
- JPMA to Advocate Improvements in NDA Review, Clinical Trial Consultation Systems
September 26, 2005
- EDC Increases Work Speed, Cuts Costs: JPMA Seminar
September 26, 2005
- ABMJ Proposes Fund for Development of New Influenza Vaccines
September 19, 2005
- TOPICS 2 articles
September 19, 2005
- Association Calls on Gov't to Support Vaccine Business
September 19, 2005
- Orders for Flu Vaccine on aPar with Last Year's: Korosho
September 19, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…